Haematology Flashcards
Multiple myeloma
- A malignancy of plasma cells (fully differential B Cells)
- Always effects bone marrow
- Destructive bone changes leading to pain & pathological fractures
- Excess plasma cells in the bone marrow
Burkitts Lymphoma
- Highly aggressive B Cell Lymphoma
- African endemic
- Young patients
- “starry sky” appearance of plasma cells
Philadelphia chromosome
- t(9:22)
- CML
B Cell Lymphoma
- One of Kappa and Lambda
CML
- Markers - CD5, CD23, CD19, CD20
- Only treat symptomatic disease
- Expression of 1 type of light chain (Kappa or Lambda)
Renal Disease in MM
# Cast nephropathy - Tubular disease-direct damage to PCT with reduced re- absorption of LC with co-ppt with Tamm-Horsfall protein in distal tubules - most common
MM
- Light Chain deposition disease: also known as monoclonal immunoglobulin deposition disease, glomerular disease - less common
- High albumin in urine
CML Treatment
1st line treatment is tyrosine kinase inhibitors;
- Imantinib
- Nilotinib; increased rates of molecular response and reduced rates of progression to blast crisis when compared to imantinib, but increased CV risk
• Avoid in patients with significant CV risk
- Dasatinib; similar responses to imantanib but SE profile worse
• Avoid in elderly & those with COPD
# Allogenic stem cell transplant – consider for patients with tyrosine kinase resistant disease or those with advanced disease eg accelerated phase or blast crisis
# Interferon alpha; previously a standard of care, now used occasionally after failure on TKIs or during pregnancy
# Hydroxyurea and bisulphan; old agents, now rarely used for CML
Howell-Jolly Bodies
- Small basophilic collections in the RBC.
- These are in fact small clusters of DNA, which are remnant from when the RBC expelled its nuclus in the bone marrow.
- In the normal person the spleen “pits” these out.
Intravascular haemolysis
- Urine haemosiderin - specific
- High LDH, High Bilirubin, low haptagloboin
Cryoprecipitate
- Fibrinogen 150–250 mg with a half-life of 100–150 hours
- Factor VIII 80-150 U with a half-life of 12 hours
- von Willebrand factor 100-150 U with a half-life of 24 hours
- Factor XIII 50-75 U with a half-life of 150–300 hours.